Cheniere Energy vs Nuwellis Inc — how do they compare? Cheniere Energy trades at $277.7 (market cap $57.39B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Cheniere Energy is far larger — about 26086.4× Nuwellis Inc's market cap, and Cheniere Energy pays a 0.8% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cheniere Energy for 10 Days and Nuwellis Inc for 26 Days on average.
| LNG | NUWE | |
|---|---|---|
Market Cap | $57.39B | $2.20M |
Volume | 1,215,835 | 121,544 |
Sector | Energy | Health |
52-Week High | $296.91 | $146.65 |
52-Week Low | $188.83 | $0.68 |
Typical Hold Time | 10 Days | 26 Days |
Enterprise Value | $82.85B | -$1.52M |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →